{"id":"W2888778641","doi":"10.1097/hco.0000000000000561","title":"SGLT2 inhibitors","year":2018,"lang":"en","type":"review","venue":"Current Opinion in Cardiology","topic":"Diabetes Treatment and Management","field":"Medicine","cited_by":12,"is_retracted":false,"has_abstract":true,"ca_institutions":"LMC Diabetes & Endocrinology (Canada); St. Michael's Hospital; Diabetes Canada; University of Toronto","funders":"Valeant Pharmaceuticals International; Sanofi; AstraZeneca","keywords":"Medicine; Canagliflozin; Empagliflozin; Glycemic; Intensive care medicine; Dapagliflozin; Renal function; Adverse effect; Type 2 Diabetes Mellitus; Diabetes mellitus; Internal medicine; Endocrinology","routes":{"ca_aff":true,"ca_fund":true,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":["metaepi_narrow","insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.0002753443,0.0004057022,0.002300194,0.0004970146,0.00002531333,0.00001024676,0.000147197,0.0003163402,0.00005190828],"category_scores_gemma":[0.00005676614,0.0003053585,0.0007414155,0.0003078837,0.000125275,0.00002847765,0.0001848372,0.0003688479,0.0007872708],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0002759627,"about_ca_system_score_gemma":0.000158882,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.000001500659,"about_ca_topic_score_gemma":1.916256e-7,"domain_scores_codex":[0.9980621,0.0001900507,0.0006145755,0.0005780761,0.0001520964,0.0004030594],"domain_scores_gemma":[0.9990638,0.00008724819,0.0001846347,0.0005175034,0.00004082345,0.0001059595],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"design_other","study_design_gemma":"not_applicable","study_design_scores_codex":[0.000004607071,0.00006054438,0.0003928386,0.0195423,0.0003004142,0.000007385148,0.000008808085,8.873813e-8,4.279767e-9,0.000209704,0.112287,0.8671863],"study_design_scores_gemma":[0.0005408482,0.0002073964,0.00007563307,0.02069815,0.0006352273,0.00003269094,0.000004126662,6.064828e-7,3.898802e-8,0.00003779202,0.9775447,0.0002227882],"study_design_candidate":"not_applicable","study_design_consensus":null,"genre_codex":"review","genre_gemma":"review","genre_scores_codex":[0.000002231557,0.9734479,0.00001256206,0.00003184451,0.02042058,0.001296696,0.00002101103,0.00006318639,0.004703978],"genre_scores_gemma":[0.000003631574,0.9935678,0.0000310074,0.000009777223,0.004547229,0.0004126733,0.001131231,0.00004307794,0.000253611],"genre_candidate":"review","genre_consensus":"review","teacher_disagreement_score":0.8669635,"threshold_uncertainty_score":0.9999908,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.1406202840832461,"score_gpt":0.4239724957529523,"score_spread":0.2833522116697061,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}